and we are down 60 cents. A $4 swing from the morning high. CELG frequently trades in sympathy with BIIB when it is down. However, interestingly there is a disconnect when BIIB is up.
One analyst price increase after another solid earnings a great job by Hugin and the stock price continues to erode. Makes no sense and we could really use the GED 031 publication now although who knows if that will be another reason it sells off.
for announcements re pharma deals as noted by Kirk. So much for "days" since it has been almost 3 weeks but the statement helped maintaining share price. No dummy at work here. Secondary is nothing but a short term blip although a little frustrating.
Chardan Capital? If that is all we have on our side we are in trouble. Perplexing and very dissapointing price action. A lot of buyers above $19.50.
Bad earnings? Earnings were great it was discounts that scared off the weak traders after hours. Nice try sleep well.
They beat and raise guidance the stock is up 7% after hours and now it is down? Appears to be no one supporting this thing and have yet to see an upgrade after a terrific quarter. What a stench.
Perhaps the time has come for the new CFO, for whom the jury is still out, starts picking up some shares.
Sure would be a good time for the GED-031 publication which was expected some time ago.